Straight from what they reported in their most recent quarterly report
Financial Performance
$4.00m in Q3 FY24 unaudited revenue, up 82% QoQ and 297% YoY.
$3.18m in Q3 Personal Testing & Supplements revenue, up 110% QoQ and 420% YoY
$0.82m in Q3 Research Testing revenue, up 20% QoQ and 107% YoY
$4.03m in Q3 FY24 cash receipts, up 217% QoQ and up 224% YoY
$7.28m in YTD FY24 unaudited revenue, up 230% YoY.
- Forums
- ASX - By Stock
- Ann: Completion of Autoimmune Program with Ginkgo Bioworks
MAP
microba life sciences limited
Add to My Watchlist
2.17%
!
9.0¢

Straight from what they reported in their most recent quarterly...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.0¢ |
Change
-0.002(2.17%) |
Mkt cap ! $46.35M |
Open | High | Low | Value | Volume |
9.5¢ | 9.5¢ | 9.0¢ | $56.78K | 623.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 192844 | 8.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 85992 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 192844 | 0.089 |
2 | 12552 | 0.088 |
3 | 64750 | 0.085 |
2 | 204868 | 0.084 |
3 | 192060 | 0.083 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 85992 | 3 |
0.093 | 20344 | 1 |
0.097 | 30161 | 1 |
0.098 | 50000 | 1 |
0.099 | 195500 | 2 |
Last trade - 13.25pm 01/08/2025 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online